This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Blucora (BCOR) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Blucora's (BCOR) first-quarter 2022 earnings and revenues are likely to have improved year over year.
Clean Harbors (CLH) to Report Q1 Earnings: What's Ahead?
by Zacks Equity Research
Clean Harbors' (CLH) first-quarter 2022 earnings and revenues are likely to have improved year over year.
What Awaits International Money Express (IMXI) in Q1 Earnings?
by Zacks Equity Research
International Money Express' (IMXI) first-quarter 2022 earnings and revenues are likely to have improved year over year.
Is a Beat in the Cards for Broadridge (BR) in Q3 Earnings?
by Zacks Equity Research
Broadridge's (BR) third-quarter fiscal 2022 earnings and revenues are expected to have increased year over year.
What's in the Cards for S&P Global (SPGI) in Q1 Earnings?
by Zacks Equity Research
S&P Global's (SPGI) first-quarter 2022 earnings are expected to have declined year over year while revenues are likely to have improved.
Verisk (VRSK) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Verisk's (VRSK) first-quarter 2022 earnings are likely to have benefited from organic growth within the business, lower interest expenses, lower effective tax rate, and a lower average share count.
Zacks.com featured highlights Revolve Group, Olympic Steel, Boise Cascade, Watsco and Cross Country Healthcare
by Zacks Equity Research
Revolve Group, Olympic Steel, Boise Cascade, Watsco and Cross Country Healthcare have been highlighted in this Screen of The Week article.
Gartner (IT) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Gartner's (IT) first-quarter 2022 earnings are expected to have declined year over year while revenues are likely to have improved.
5 DuPont-Tested Winning Stocks to Buy Now
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
Cross Country Healthcare (CCRN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cross Country (CCRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Visa's (V) Q2 Earnings Beat Estimates on Solid Payments Volume
by Zacks Equity Research
Visa's (V) fiscal second-quarter results indicate better payments volume, processed transactions and cross-border volume, partly offset by high operating costs.
Waste Management (WM) Q1 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
Waste Management's (WM) first-quarter 2022 earnings and revenues increase year over year.
Insperity, Inc. (NSP) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 9.34% and 6.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cross Country Healthcare (CCRN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $20.45, marking a -0.15% move from the previous day.
FTI Consulting (FCN) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
FTI Consulting's (FCN) first-quarter 2022 revenues are likely to have increased year over year.
Factors Setting the Tone for Mastercard's (MA) Q1 Earnings
by Zacks Equity Research
Mastercard's (MA) first-quarter earnings are likely to reflect higher worldwide GDV, improved consumer spending and rebounding cross-border volumes, partly offset by increased operating expenses.
Interpublic (IPG) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Interpublic's (IPG) first-quarter 2022 revenues are expected to have increased year over year while earnings are likely to have declined.
5 Broker-Friendly Stocks to Tide Over Market Mayhem
by Maharathi Basu
For lucrative returns, investors should keep broker-friendly stocks like United Airlines (UAL), C.H. Robinson (CHRW), Cross Country Healthcare (CCRN), PBF Energy (PBF) and Cleveland-Cliffs (CLF) on their radar.
What's in the Offing for Robert Half (RHI) in Q1 Earnings?
by Zacks Equity Research
Robert Half's (RHI) first-quarter 2022 earnings and revenues are likely to have improved on a year-over-year basis.
Rollins (ROL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Rollins' (ROL) first-quarter 2022 revenues are expected to have increased year over year.
TransUnion (TRU) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
TransUnion's (TRU) first-quarter 2022 earnings and revenues are likely to have increased year over year.
Fiserv (FISV) Set to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Fiserv's (FISV) first-quarter 2022 earnings and revenues are likely to have improved year over year.
What's in the Cards for IQVIA Holdings (IQV) in Q1 Earnings?
by Zacks Equity Research
IQVIA Holdings' (IQV) first-quarter 2022 earnings and revenues are likely to have increased year over year.
Xerox (XRX) Reports Loss in Q1, Revenues Surpass Estimates
by Zacks Equity Research
Xerox's (XRX) first-quarter 2022 revenues decrease year over year.
Equifax (EFX) Q1 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
Equifax's (EFX) first-quarter 2022 earnings and revenues increase year over year.